| Literature DB >> 27679531 |
Abdulrahman Darraj1, Walid Barakat1, Mona Kenani1, Reem Shajry1, Abdullah Khawaji1, Sultan Bakri1, Abdulrahman Makin1, Azza Mohanna1, Abu Obaida Yassin1.
Abstract
BACKGROUND: The rise in childhood eye diseases has become a matter of concern in Saudi Arabia, and hence a study has been conducted on the residents of Jazan. The aim of the research was to find out the root cause of such issues and provide a solution to prevent such circumstances for it may affect the vision of children. In this study, therefore, we aimed to determine the types of childhood eye diseases in Jazan and to discuss the best ways to prevent them or prevent their effect on the vision of our children. Our institutions are working toward the longevity and welfare of the residents, and healthcare is one of the important aspects in such a field.Entities:
Keywords: Jazan; amblyopia; keratoconus; pediatric ocular disorders; refractive errors; strabismus
Year: 2016 PMID: 27679531 PMCID: PMC5030826 DOI: 10.4137/OED.S39055
Source DB: PubMed Journal: Ophthalmol Eye Dis ISSN: 1179-1721
Figure 1Age group and sex distribution of children.
Figure 2Spectrum and frequency of eye morbidities seen.
Abbreviations: RE, refractive error; NLDO, nasolacrimal duct obstruction.
Figure 3Types of refractor error.
Types of treatment.
| TREATMENT | FREQUENCY | PERCENT | VALID PERCENT | CUMULATIVE PERCENT |
|---|---|---|---|---|
| None | 24 | 6.2 | 6.2 | 6.2 |
| Amblyopia treatment | 61 | 17.3 | 17.3 | 23.5 |
| Medication | 48 | 12.5 | 11.4 | 19.0 |
| CXL | 11 | 2.9 | 2.9 | 21.8 |
| Strab surgery | 17 | 4.42 | 3.4 | 25.2 |
| Botox | 5 | 1.3 | 3.1 | 28.3 |
| Surgery (cataract surgery) (probing) | 40 | 10.4 | 10.4 | 38.7 |
| Glasses | 156 | 40.5 | 40.5 | 79.2 |
| Contact lens | 9 | 2.3 | 2.3 | 81.6 |
| NLD massage | 4 | 1.0 | 1.0 | 82.6 |
| Total | 385 | 100.0 | 100.0 | 100 |
Abbreviations: PTO, part-time occlusion; CXL, corneal cross-linking; NLD, nasolacrimal duct.
Distribution of RE subtypes among school-age children in different studies from Saudi Arabia.
| STUDIES | YEAR | AGE GROUP | SAMPLE SIZE | PREVALENCE OF RE. (%) | MYOPIA (%) | HYPEROPIA (%) |
|---|---|---|---|---|---|---|
| Abu-shagra et al. | 1991 | 6–9 | 1188 | 10 | 50 | 15 |
| Ali et al. | 2007 | 10–16 | 540 | 19.8 | 43 | 21.5 |
| Hashim et al. | 2008 | 10–15 | 840 | 7.0 | 77.5 | 14.3 |
| Al-Nuaimi. | 2010 | 6–13 | 670 | 19.7 | 73 | 17 |
| Al-Rowaily and Alainizi. | 2010 | 12–13 | 1536 | 9.8 | 57.6 | 15.2 |
| Al-Wadaani et al. | 2013 | 6–14 | 2002 | 13.7 | 65.7 | 12.4 |
| Al-Tmimi and Shakeel. | 2013 | 5–15 | 1350 | 44.4 | 13.3 | 83 |
| Current study | 2016 | 0–18 | 385 | 26.5 | 21.3 | 35.8 |
Spectrum of childhood eye disorders according to the gender and age groups.
| DIAGNOSIS | GENDER OF PATIENT | TOTAL (%) | 0–6 (%) | 60–12 (%) | 120–18 (%) | TOTAL (%) | |
|---|---|---|---|---|---|---|---|
| MALE (%) | FEMALE (%) | ||||||
| Strabismus | 66 | 76 | 142 | 65 | 54 | 23 | 142 |
| 36.70% | 37% | 36.90% | 45.50% | 42.20% | 20.20% | 36.90% | |
| Infection | 9 | 19 | 28 | 12 | 7 | 9 | 28 |
| 5.00% | 9.30% | 7.30% | 8.40% | 5.50% | 7.90% | 7.30% | |
| Trauma | 19 | 10 | 29 | 8 | 5 | 16 | 29 |
| 10.60% | 4.90% | 7.50% | 5.60% | 3.90% | 14.00% | 7.50% | |
| Cataract | 6 | 3 | 9 | 7 | 1 | 1 | 11 |
| 3.30% | 1.50% | 2.30% | 4.90% | 0.80% | 0.90% | 2.30% | |
| Glaucoma | 3 | 7 | 10 | 3 | 2 | 5 | 10 |
| 1.70% | 3.40% | 2.60% | 2.10% | 1.60% | 4.40% | 2.60% | |
| Refractive error | 44 | 58 | 102 | 26 | 49 | 27 | 102 |
| 24.40% | 28.30% | 26.50% | 18.20% | 38.30% | 23.70% | 26.50% | |
| Eyelid disease | 4 | 9 | 13 | 6 | 5 | 2 | 13 |
| 2.20% | 4.40% | 3.40% | 4.20% | 3.90% | 1.80% | 3.40% | |
| Keratoconus | 13 | 11 | 24 | 0 | 0 | 24 | 24 |
| 7.20% | 5.40% | 6.20% | 0.00% | 0.00% | 21.10% | 6.20% | |
| Allergic conjunctivitis/VKC | 4 | 1 | 5 | 1 | 0 | 4 | 5 |
| 2.20% | 0.50% | 1.30% | 0.70% | 0.00% | 3.50% | 1.30% | |
| Retinal disease | 8 | 3 | 11 | 4 | 4 | 3 | 11 |
| 4.40% | 1.50% | 2.90% | 2.80% | 3.10% | 2.60% | 2.90% | |
| NLDO | 4 | 6 | 10 | 10 | 0 | 0 | 10 |
| 2.20% | 2.90% | 2.60% | 7.00% | 0.00% | 0.00% | 2.60% | |
| Ptosis | 0 | 2 | 2 | 1 | 1 | 0 | 2 |
| 0.00% | 1% | 0.50% | 0.70% | 0.80% | 0.00% | 0.50% | |
| Total | 180 | 205 | 385 | 143 | 128 | 114 | 385 |
| 46.80% | 53.20% | – | 37.10% | 33.20% | 29.60% | – | |
Note: The spectrum and frequency of eye morbidities are given according to the gender and age groups.